SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-021008
Filing Date
2021-08-23
Accepted
2021-08-23 16:24:30
Documents
13
Period of Report
2021-08-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38231
  Complete submission text file 0001493152-21-021008.txt   262942

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrow-20210819.xsd EX-101.SCH 3747
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrow-20210819_def.xml EX-101.DEF 28160
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrow-20210819_lab.xml EX-101.LAB 37404
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrow-20210819_pre.xml EX-101.PRE 26775
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5544
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 211197124
SIC: 2834 Pharmaceutical Preparations